Liraglutide 3.0 mg within a NHS Tier-3/4 weight management service results in similar weight loss compared to regulatory trials - The LIPOSAX first UK real-world evidence study

2021 ◽  
Author(s):  
Georgios K Dimitriadis ◽  
Lewis Spencer ◽  
Federica Dimitri ◽  
Danielle Bate ◽  
Bianca M Leca ◽  
...  
2020 ◽  
Author(s):  
H Deshmukh ◽  
S Benamer ◽  
K Linn ◽  
T Sathyapalan ◽  
K Mohammed

2020 ◽  
Vol 20 (2) ◽  
pp. 117-121
Author(s):  
Aliya Syahreni Prihartadi* ◽  
Giovanna Impelliziere Licastro* ◽  
Harshal Deshmukh ◽  
Sufyan Benamer ◽  
Kyaw Linn ◽  
...  

Introduction: A specialist weight management service provides an effective treatment option for severe obesity; however, there are limited data exploring the baseline predictors of response and effect on HbA1c following engagement with the service.Methods: We used prospective data from the regional weight management services within the Hull University Teaching Hospitals NHS Trust Tier 3 Obesity Programme. Data were available for 249 patients referred to the service. T-tests were used for univariate baseline characteristics of those with and without 5% weight loss after engagement with the service. Logistic regression analysis was used to identify independent predictors of weight loss at 12 months.Results: A total of 309 patients were referred to the Tier 3 adult weight management service, of which 249 (80.6%) participated in the programme and had at least one follow-up. The median age of the study population was 46 years (range 36–55) and consisted of 66% females with a median baseline body mass index of 44 kg/m2 (range 42–45). The prevalence of type 2 diabetes was 31%, hypertension was 35%, gastro-oesophageal reflux disease was 34% and osteoarthritis was 29%. The median baseline weight on enrolment in the programme was 126 kg (range 115–138). During the follow-up period of 1 year, the median weight fell to 120.5 kg at 3 months, 119.6 kg at 6 months, 117.7 kg at 9 months and 117.5 kg at 12 months. The median HbA1c fell from a baseline of 60.25 mmol/mol to 54.4 mmol/mol during the follow-up period. Sixty-four patients had a baseline HbA1c of >53 mmol/mol (7% HbA1c), which fell to <53 mmol/mol in 21% of patients during the follow-up period. In the logistic regression model, higher age (OR 1.05, p=0.0001), type 2 diabetes (OR 2.54, p=0.002) and dyslipidaemia (OR 2.21, p=0.03) were independently associated with more than 5% weight loss at 12 months follow-up.Conclusion: Engagement with Tier 3 adult weight management is associated with significant weight loss and improvement in glycaemic control in a large proportion of patients at one year. Higher age, diabetes and dyslipidaemia at baseline are independent predictors of weight loss on the Tier 3 weight management service.


2019 ◽  
Author(s):  
Rhodri King ◽  
Damian Hareteh ◽  
Wentian Fang ◽  
Amy Bull ◽  
Alice Murray-Gourlay ◽  
...  

2018 ◽  
Author(s):  
Tessa Glyn ◽  
May Ho ◽  
Anthony Paul Lambert ◽  
Julia Thomas ◽  
Rhodri King ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document